MAP2K7 and neoplasm: Herein, this study indicated that RDM1 caused an increase in cell proliferation in vitro and tumour growth in vivo, as well as the inhibition of cell apoptosis via inducing cell cycle transition from G1 to S stage, and activating MEK/ERK signalling pathway.